Skip to main content
    P

    Pacira BioSciences, Inc. (PCRX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $36.48
    +0.02 (+0.05%)

    Market Cap: $1.46B

    Last updated: Nov 17, 2026 at 3:04 AM ET

    Pacira BioSciences, Inc. (PCRX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Pacira BioSciences are Phibro Animal Health (PAHC), Collegium Pharmaceutical (COLL) and Perrigo Company (PRGO). Pacira BioSciences trades at 20.0x earnings, against a median of 10.7x for the 11 of these companies with a P/E. By market cap, Pacira BioSciences ranks 8th of the 13 companies on this page; Xeris Pharmaceuticals (XERS) is the largest at $3.04B.

    Peer Comparison

    PCRX's ROIC of 4.2% is below the peer median of 9.9%, and its revenue growth of -1.6% is below the median of 13.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Pacira BioSciences (PCRX)$1.46B20.0x2.0x5.1%4.2%-1.6%0.00%
    Phibro Animal Health Corporation (PAHC)$1.46B10.7x0.9x6.7%11.7%6.3%1.37%
    Collegium Pharmaceutical Inc (COLL)$786.83M3.7x1.0x4.7%8.1%3.3%0.00%
    Perrigo Company PLC (PRGO)$2.25B7.0x0.6x-43.3%-26.3%-5.2%7.17%
    BioCryst Pharmaceuticals Inc (BCRX)$1.96B4.4x2.0x-37.4%24937.1%13.1%0.00%
    Amphastar P (AMPH)$1.25B10.3x1.7x13.3%7.9%8.2%0.00%
    Supernus Pharmaceuticals, Inc. (SUPN)$1.52B12.7x2.0x32.8%N/A13.4%0.00%
    Harrow Health Inc (HROW)$1.13BN/A3.6x-9.4%-0.3%38.6%0.00%
    Prestige Brand Holdings Inc (PBH)$2.19B10.7x2.0x13.3%5.0%22.7%0.00%
    Ironwood Pharmaceuticals Inc (IRWD)$799.61M5.4x2.0x37.4%70.5%9.0%0.00%
    Cronos Group Inc (CRON)$1.24B28.4x5.6x28.0%N/A74.6%0.00%
    Xeris Pharmaceuticals Inc (XERS)$3.04B139.2x8.2x-1.8%15.5%44.2%0.00%
    Eton Pharmaceuticals Inc (ETON)$1.84B36.7x13.0x35.3%37.0%157.9%0.00%
    Peer median$1.49B10.7x2.0x10.0%9.9%13.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Pacira BioSciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Phibro Animal Health Corporation (PAHC)
    Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily...
    PAHC competitors
    Collegium Pharmaceutical Inc (COLL)
    Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications.
    COLL competitors
    Perrigo Company PLC (PRGO)
    Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
    PRGO competitors
    BioCryst Pharmaceuticals Inc (BCRX)
    BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
    BCRX competitors
    Amphastar P (AMPH)
    Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation...
    AMPH competitors
    Supernus Pharmaceuticals, Inc. (SUPN)
    Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases...
    SUPN competitors
    Harrow Health Inc (HROW)
    Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
    HROW competitors
    Prestige Brand Holdings Inc (PBH)
    Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States...
    PBH competitors
    Ironwood Pharmaceuticals Inc (IRWD)
    Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.
    IRWD competitors
    Cronos Group Inc (CRON)
    Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
    CRON competitors
    Xeris Pharmaceuticals Inc (XERS)
    Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations.
    XERS competitors
    Eton Pharmaceuticals Inc (ETON)
    Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases.
    ETON competitors

    Frequently Asked Questions About PCRX

    Who are Pacira BioSciences' main competitors?

    The companies most similar to Pacira BioSciences include Phibro Animal Health (PAHC), Collegium Pharmaceutical (COLL), Perrigo Company (PRGO), BioCryst Pharmaceuticals (BCRX) and Amphastar (AMPH), listed from the closest match.

    Who is Pacira BioSciences' biggest competitor?

    Xeris Pharmaceuticals (XERS) is the largest of the similar companies at $3.04B; Phibro Animal Health (PAHC) is the closest match by business profile, size, sector and industry.

    How does PCRX stock compare with its competitors?

    PCRX's P/E is 20.0x against a peer median of 10.7x; its P/S is 2.0x against a peer median of 2.0x; its net margin is 5.1% against a peer median of 10.0%.

    Which of Pacira BioSciences' competitors pays a higher dividend?

    Pacira BioSciences pays no dividend. Perrigo Company (PRGO) and Phibro Animal Health (PAHC) have higher forward dividend yields; Perrigo Company (PRGO) has the highest at 7.17%.

    Is Pacira BioSciences bigger than its competitors?

    No. Pacira BioSciences is 8th by market cap among the 13 companies on this page; the largest is Xeris Pharmaceuticals (XERS) at $3.04B.